Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial-Reference-Cited by-同舟云学术

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial

Published:2013-10-09 Issue:1 Volume:109 Page:79-87
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Hser Yih-Ing¹,Saxon Andrew J.²,Huang David¹,Hasson Al¹,Thomas Christie¹,Hillhouse Maureen¹,Jacobs Petra³,Teruya Cheryl¹,McLaughlin Paul⁴,Wiest Katharina⁵,Cohen Allan⁶,Ling Walter¹

Affiliation:

1. University of California; Los Angeles CA USA

2. Veterans Affairs Puget Sound Health Care System; Seattle WA USA

3. National Institute on Drug Abuse; Bethesda ML USA

4. Hartford Dispensary; CT USA

5. CODA, Inc.; OR USA

6. Bay Area Addiction Research and Treatment; CA USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/add.12333/fullpdf

Reference35 articles.

1. Substance Abuse and Mental Health Services Administration (SAMHSA) Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings SAMHSA 2011

2. Extent of illicit drug use and dependence, and their contribution to the global burden of disease;Degenhardt;Lancet,2012

3. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation;Connock;Health Technol Assess,2007

4. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment;Bell;Addiction,2009

Cited by 330 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of full and partial opioid agonists for opioid use disorder in outpatient settings: United States healthcare sector perspective;Journal of Substance Use and Addiction Treatment;2024-05

2. Is that a treatment program? Examining the physical landscape of opioid treatment programs in Los Angeles;Journal of Substance Use and Addiction Treatment;2024-04

3. Low-dose buprenorphine initiation and treatment continuation among hospitalized patients with opioid dependence: A retrospective cohort study;Journal of Substance Use and Addiction Treatment;2024-03

4. Mobile Medication Adherence Platform for Buprenorphine (MAP4BUP): A Phase I feasibility, usability and efficacy pilot randomized clinical trial;Drug and Alcohol Dependence;2024-03

5. Medical and genetic correlates of long-term buprenorphine treatment in the electronic health records;Translational Psychiatry;2024-01-10